Head and Neck Diseases by Alexandros G.Sfakianakis: Comments on “Low-dose-rate prostate brachytherapy: 4–8 week postimplant prostate-specific antigen a novel predictor of biochemical failure-free survival”

Κυριακή 21 Ιανουαρίου 2018

Comments on “Low-dose-rate prostate brachytherapy: 4–8 week postimplant prostate-specific antigen a novel predictor of biochemical failure-free survival”

Publication date: Available online 10 January 2018
Source:Brachytherapy
Author(s): Kamyar Mansori, Erfan Ayubi, Saeid Safiri

http://ift.tt/2DyBBhu

Head and Neck Diseases by Alexandros G.Sfakianakis

Κυριακή 21 Ιανουαρίου 2018

Comments on “Low-dose-rate prostate brachytherapy: 4–8 week postimplant prostate-specific antigen a novel predictor of biochemical failure-free survival”

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου